drugset / Trial / NCT00835991

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed

NCT00835991

Phase 1 Completed 60 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of Glyburide/Metformin 5 mg/500 mg film-coated tablets (test) versus Glucovance® (reference) administered as 1 x 5 mg/500 mg film-coated tablet under fed conditions.

Timeline

Start
2003-02
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Glyburide Small molecule 5 mg
Subject Metformin Small molecule 500 mg

Indications

No indication recorded.